Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cytokinetics

Cytokinetics
1997 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
CYTK STOCK SYMBOL
$9.63 SHARE PRICE (As of Monday Closing)
Description

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatment for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 280 East Grand Avenue
  • South San Francisco, CA 94080
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cytokinetics’s full profile, request a free trial.

Cytokinetics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$5.75 - $14.94 $570M $9.42 -$2.08 729K 59.2M

Cytokinetics Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 548,203 177,368 161,893 443,413
Revenue 31,033 31,501 13,368 106,407
EBITDA (96,037) (87,677) (111,476) 19,428
Net Income (117,520) (106,289) (127,790) 16,453
Total Assets 187,393 211,178 294,810 170,142
Total Debt 52,596 42,413 31,777 29,881
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cytokinetics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cytokinetics‘s full profile, request access.

Request full access to PitchBook

Cytokinetics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Cytokinetics‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Cytokinetics Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Essa Pharma Formerly PE-Backed Vancouver, Canada 00 00000 00000000 00000
000000000 00000000 Corporation Pasadena, CA 000 00.000 0000
000000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
0000000 0000000000 Formerly VC-backed Cambridge, MA 000 00.000 00000000 00.000
000000 Venture Capital-Backed San Diego, CA 0 00.000 0000000000 0 00.000
To view this company’s complete list of competitors, request access »

Cytokinetics Executive Team (5)

Name Title Board
Seat
Contact
Info
Robert Blum Chief Executive Officer & Board Member
Sharon Barbari Executive Vice President, Finance & Chief Financial Officer
Mark Schlossberg General Counsel & Senior Vice President

2 Former Executives

You’re viewing 3 of 5 executives. Get the full list »

Cytokinetics Board Members (7)

Name Representing Role Since Contact
Info
Edward Kaye MD Self Board Member 000 0000
John Henderson MD Self Board Member 000 0000
Patrick Gage Ph.D Self Chairman of the Board 000 0000
Robert Blum Cytokinetics Chief Executive Officer & Board Member 000 0000
Robert Califf MD Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »